Get started
Lavipharm SALavipharm SALavipharm SA

Lavipharm SA

No trades
OverviewFinancialsNewsCommunityTechnicalsSeasonals

Chart


Full chart

Key stats


Market capitalization
‪228.88 M‬ EUR
Dividend yield (indicated)
1.48%
Price to earnings Ratio (TTM)
59.126
Basic EPS (TTM)
0.022 EUR
Net income (FY)
‪8.98 M‬ EUR
Revenue (FY)
‪52.95 M‬ EUR
Shares float
‪69.19 M‬
Beta (1Y)
0.87

Employees


Employees (FY)
299
Change (1Y)
−8 −2.61%
Revenue / Employee (1Y)
‪177.08 K‬ EUR
Net income / Employee (1Y)
‪28.99 K‬ EUR

About Lavipharm SA


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
lavipharm.com
Headquarters
Paiania
Founded
1911
IPO date
Nov 8, 1995
Identifiers
2
ISIN GRS246003008
Lavipharm SA engages in the manufacture and import of pharmaceuticals and veterinary products. It offers products such as pharmaceuticals, over the counter medicines, and dermacosmetics. The company was founded in 1911 and is headquartered in Paiania, Greece.

Check out other big names from the same industry as LAVI.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of LAVI is 1.446 EUR — it has increased by 3.25% in the past 24 hours. Watch Lavipharm SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ATHEX exchange Lavipharm SA stocks are traded under the ticker LAVI.
LAVI stock has risen by 0.29% compared to the previous week, the month change is a 41.21% rise, over the last year Lavipharm SA has showed a 76.34% increase.
LAVI reached its all-time high on Jan 15, 2007 with the price of 6.198 EUR, and its all-time low was 0.050 EUR and was reached on Sep 19, 2016. View more price dynamics on LAVI chart.
See other stocks reaching their highest and lowest prices.
LAVI stock is 5.04% volatile and has beta coefficient of 0.87. Track Lavipharm SA stock price on the chart and check out the list of the most volatile stocks — is Lavipharm SA there?
Today Lavipharm SA has the market capitalization of ‪236.32 M‬, it has decreased by −5.45% over the last week.
Yes, you can track Lavipharm SA financials in yearly and quarterly reports right on TradingView.
LAVI net income for the last half-year is ‪2.63 M‬ EUR, while the previous report showed ‪1.24 M‬ EUR of net income which accounts for 112.12% change. Track more Lavipharm SA financial stats to get the full picture.
Yes, LAVI dividends are paid annually. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (TTM)% is 1.43%. Tracking Lavipharm SA dividends might help you take more informed decisions.
Lavipharm SA dividend yield was 2.52% in 2024, and payout ratio reached 37.45%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 12, 2026, the company has 299 employees. See our rating of the largest employees — is Lavipharm SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lavipharm SA EBITDA is ‪9.64 M‬ EUR, and current EBITDA margin is 16.69%. See more stats in Lavipharm SA financial statements.
Like other stocks, LAVI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lavipharm SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lavipharm SA technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lavipharm SA stock shows the strong buy signal. See more of Lavipharm SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.